Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 527 | 128 | 42 | 8 | 31 |
| Receivables | 75 | 66 | 66 | 60 | 45 |
| TOTAL | $611 | $228 | $145 | $86 | $110 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 4 | 4 | 4 |
| Intangibles | 1,053 | 1,034 | 1,068 | 1,060 | 981 |
| TOTAL | $1,056 | $1,037 | $1,072 | $1,064 | $986 |
| Total Assets | $1,667 | $1,265 | $1,217 | $1,150 | $1,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 71 | 132 | 237 | 271 | 165 |
| TOTAL | $152 | $316 | $456 | $649 | $379 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8 | 0 | 0 | 0 | 0 |
| TOTAL | $8 | $0 | $0 | $0 | $0 |
| Total Liabilities | $160 | $316 | $456 | $649 | $379 |
| Shareholders' Equity | |||||
| Common Shares | 25,837 | 25,211 | 25,304 | 24,778 | 23,101 |
| Retained earnings | -29,520 | -29,464 | -29,619 | -29,133 | -26,959 |
| Other shareholders' equity | 76 | 122 | 102 | 0 | 33 |
| TOTAL | $1,507 | $950 | $761 | $501 | $717 |
| Total Liabilities And Equity | $1,667 | $1,265 | $1,217 | $1,150 | $1,096 |